Pabros, Baby Girl .
HRN: 27-95-72 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/23/2025
AMPICILLIN 250MG (VIAL)
10/23/2025
10/30/2025
IV
115 Mg
Q 12
Neonate Affected By Maternal Factor
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes